| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0098 | 0.9 |